Does DAPAGLIFLOZIN Cause Hyperammonaemia? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hyperammonaemia have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.1% of all adverse event reports for DAPAGLIFLOZIN.
12
Reports of Hyperammonaemia with DAPAGLIFLOZIN
0.1%
of all DAPAGLIFLOZIN reports
2
Deaths
12
Hospitalizations
How Dangerous Is Hyperammonaemia From DAPAGLIFLOZIN?
Of the 12 reports, 2 (16.7%) resulted in death, 12 (100.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Hyperammonaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Hyperammonaemia?
VALPROIC ACID (581)
VALPROATE (328)
FLUOROURACIL (263)
DIVALPROEX (256)
LEVETIRACETAM (192)
TACROLIMUS (181)
ACETAMINOPHEN (177)
OXALIPLATIN (160)
TOPIRAMATE (156)
GLYCEROL PHENYLBUTYRATE (147)
Which DAPAGLIFLOZIN Alternatives Have Lower Hyperammonaemia Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN